Skip to main content

MoneyWorks4Me

Aarti Drugs informs about updates on buyback offer

17 Jan 2018 Evaluate

Inga Capital (Formerly Inga Capital) (Manager to the Buyback Offer) has submitted a copy of Draft Letter of Offer for the attention of Equity Shareholders / Beneficial Owners of Aarti Drugs (Target Company).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1758.00
Dr. Reddys Labs. 1335.40
Cipla 1360.00
Lupin 1971.00
Zydus Lifesciences 1172.00
View more..